Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma.

Hematology Reports
Dino Amadori

Abstract

Anthracyclines have a central role in the management of non-Hodgkin's lymphoma (NHL). The cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) treatment regimen has been the standard of care for more than 20 years. Further improvements have been made to the efficacy of this chemotherapy by reducing the dosing interval and adding rituximab to the regimen. A major limitation to the use of anthracyclines is the development of cardiotoxicity as a late adverse event. Strategies to reduce cardiac events include changes to the dosing schedule for doxorubicin, use of the chelating agent dexrazoxane and the use of liposome-encapsulated doxorubicin. This latter strategy has demonstrated good efficacy and reduced cardiotoxicity in patients with NHL, including those at risk of developing cardiac effects.

References

Nov 1, 1979·Annals of Internal Medicine·D D Von HoffF M Muggia
Aug 30, 1969·British Medical Journal·G BonadonnaF Fossati-Bellani
Feb 1, 1982·Annals of Internal Medicine·S S LeghaE J Freireich
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·K L Cheung, J F Robertson
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnJoseph M Connors
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M HabermannSandra J Horning
Oct 21, 2006·The Cochrane Database of Systematic Reviews·E C van DalenL C M Kremer
Jan 30, 2008·The Lancet Oncology·Michael PfreundschuhUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Apr 22, 2008·The Cochrane Database of Systematic Reviews·E C van DalenL C M Kremer
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Elvira C van DalenLeontien Cm Kremer

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.